Impact of Phase 2b strategies on optimization of drug development programs

Christopher Jennison, Zoran Antonijevic, Jim Bolognese, Carl-Fredrik Burman, Christy Chuang-Stein, Martin Kimber, Olga Marchenko, Nitin Patel, Jose Pinheiro

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish
Title of host publicationOptimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy
Place of PublicationHeidelberg
PublisherSpringer
Pages83-103
ISBN (Electronic)978-3-319-09075-7
ISBN (Print)978-3-319-09074-0
DOIs
Publication statusPublished - 2015

Cite this

Jennison, C., Antonijevic, Z., Bolognese, J., Burman, C-F., Chuang-Stein, C., Kimber, M., ... Pinheiro, J. (2015). Impact of Phase 2b strategies on optimization of drug development programs. In Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy (pp. 83-103). Heidelberg: Springer. https://doi.org/10.1007/978-3-319-09075-7_6